Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT07460362 · RECRUITING
Trial details
- NCT number
- NCT07460362
- Sponsor
- Peking University Third Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2027-12-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.